Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew McGarry

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Lancet. Neurology|May 17, 2024
Negative findings from trials with NLY01 or deferiprone for Parkinson's disease - Author's replyAndrew McGarry
Neurology|April 8, 2020
Author response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trialAndrew McGarry
Parkinsonism & Related Disorders|April 9, 2013
Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and ParkinsonismAndrew McGarry, Kevin Biglan
Handbook of Clinical Neurology|February 21, 2023
Adaptive clinical trials and master protocolsAndrew McGarry, Karl Kieburtz
Brain Sciences|January 24, 2025
A Pilot Proteomic Analysis of Huntington's Disease by Functional CapacityAndrew McGarry, Ruin Moaddel
Handbook of Clinical Neurology|September 27, 2017
Preclinical motor manifestations of Huntington diseaseAndrew McGarry, Kevin M Biglan
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2020
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another PandemicKarl Kieburtz, Russell Katz, Andrew McGarry, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2011
Pharmacologic approaches to the treatment of Huntington's diseaseCharles S Venuto, Andrew McGarry, Qing Ma, et al.
Journal of Huntington'S Disease|January 28, 2020
Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's DiseaseAndrew McGarry, Michael P McDermott, Karl Kieburtz, et al.
Clinical Parkinsonism & Related Disorders|January 23, 2026
Explore thyself: is it time for metacognition screening in clinical trials?Andrew McGarry, Scott Y H Kim, Peggy Auinger, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. Neurology|May 17, 2024
Negative findings from trials with NLY01 or deferiprone for Parkinson's disease - Author's replyAndrew McGarry
Neurology|April 8, 2020
Author response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trialAndrew McGarry
Parkinsonism & Related Disorders|April 9, 2013
Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and ParkinsonismAndrew McGarry, Kevin Biglan
Handbook of Clinical Neurology|February 21, 2023
Adaptive clinical trials and master protocolsAndrew McGarry, Karl Kieburtz
Brain Sciences|January 24, 2025
A Pilot Proteomic Analysis of Huntington's Disease by Functional CapacityAndrew McGarry, Ruin Moaddel
Handbook of Clinical Neurology|September 27, 2017
Preclinical motor manifestations of Huntington diseaseAndrew McGarry, Kevin M Biglan
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2020
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another PandemicKarl Kieburtz, Russell Katz, Andrew McGarry, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2011
Pharmacologic approaches to the treatment of Huntington's diseaseCharles S Venuto, Andrew McGarry, Qing Ma, et al.
Journal of Huntington'S Disease|January 28, 2020
Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's DiseaseAndrew McGarry, Michael P McDermott, Karl Kieburtz, et al.
Clinical Parkinsonism & Related Disorders|January 23, 2026
Explore thyself: is it time for metacognition screening in clinical trials?Andrew McGarry, Scott Y H Kim, Peggy Auinger, et al.
Pageof 4